These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7284581)

  • 21. The carrier potential of liposomes in biology and medicine (second of two parts).
    Gregoriadis G
    N Engl J Med; 1976 Sep; 295(14):765-70. PubMed ID: 785256
    [No Abstract]   [Full Text] [Related]  

  • 22. Enzyme replacement therapy for lysosomal storage disorders: successful transition from concept to clinical practice.
    Sly WS
    Mo Med; 2004; 101(2):100-4. PubMed ID: 15119106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enzyme--cell membrane recognition (what we can learn from rare genetic lysosomal disorders).
    Wiesmann UN; Di Donato S
    Biochem Exp Biol; 1977; 13(1):7-14. PubMed ID: 26366
    [No Abstract]   [Full Text] [Related]  

  • 24. Enzyme manipulation: mechanisms and therapeutic trials--summary and discussion.
    Hommes FA
    Birth Defects Orig Artic Ser; 1980; 16(1):335-40. PubMed ID: 7448360
    [No Abstract]   [Full Text] [Related]  

  • 25. [Enzymatic substitution therapy in either non-purified or purified form].
    Srses S
    Cesk Pediatr; 1976 Mar; 31(3):150-3. PubMed ID: 1269013
    [No Abstract]   [Full Text] [Related]  

  • 26. [Lysosomes and lysosomal storage diseases].
    Germain DP
    J Soc Biol; 2002; 196(2):127-34. PubMed ID: 12360741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Future possibilities for the treatment of hereditary metabolic diseases].
    Watts RW
    Monatsschr Kinderheilkd; 1983 Jun; 131(6):305-10. PubMed ID: 6350850
    [No Abstract]   [Full Text] [Related]  

  • 28. Immobilized enzymes. Their applications in medicine.
    Anderson PM; Salo WL
    Minn Med; 1973 Dec; 56(12):1036-40. PubMed ID: 4800830
    [No Abstract]   [Full Text] [Related]  

  • 29. Microbial enzymes in clinical investigation, diagnosis and therapy.
    Smith CE
    J Gen Microbiol; 1971 Mar; 65(3):x. PubMed ID: 5556685
    [No Abstract]   [Full Text] [Related]  

  • 30. A counterintuitive approach to treat enzyme deficiencies: use of enzyme inhibitors for restoring mutant enzyme activity.
    Fan JQ
    Biol Chem; 2008 Jan; 389(1):1-11. PubMed ID: 18095864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enzyme-containing liposomes alleviate a model for storage disease.
    Gregoriadis G; Buckland RA
    Nature; 1973 Jul; 244(5412):170-2. PubMed ID: 4583499
    [No Abstract]   [Full Text] [Related]  

  • 32. Biological approaches to the controlled delivery of drugs: a critical review.
    Poznansky MJ; Juliano RL
    Pharmacol Rev; 1984 Dec; 36(4):277-336. PubMed ID: 6395142
    [No Abstract]   [Full Text] [Related]  

  • 33. [Drug-induced lysosomal release in experimental phospholipidosis].
    Joh K; Riede UN
    Verh Dtsch Ges Pathol; 1982; 66():324-8. PubMed ID: 7184255
    [No Abstract]   [Full Text] [Related]  

  • 34. [Endocannabinoid type 1 receptor antagonists].
    Girard J; Sauvanet JP
    Soins; 2008 Apr; (724 Suppl):S14-5, S18-9. PubMed ID: 18496973
    [No Abstract]   [Full Text] [Related]  

  • 35. [Gene therapy in lysosomal diseases].
    Moullier P; Salvetti A; Bohl D; Danos O; Heard JM
    C R Seances Soc Biol Fil; 1996; 190(1):45-51. PubMed ID: 8881268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Who picks up the costs of expensive enzyme replacement therapy?].
    Kaitila I
    Duodecim; 2004; 120(20):2375-7. PubMed ID: 15641506
    [No Abstract]   [Full Text] [Related]  

  • 37. Red cell enzyme deficiencies: from genetic basis to gene transfer.
    Mason PJ
    Semin Hematol; 1998 Apr; 35(2):126-35. PubMed ID: 9565155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biosynthesis of lysosomal proteinases in health and disease.
    Mach L
    Biol Chem; 2002 May; 383(5):751-6. PubMed ID: 12108539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene therapy: prospects for glycolipid storage diseases.
    Gieselmann V; Matzner U; Klein D; Mansson JE; D'Hooge R; DeDeyn PD; Lüllmann Rauch R; Hartmann D; Harzer K
    Philos Trans R Soc Lond B Biol Sci; 2003 May; 358(1433):921-5. PubMed ID: 12803926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secretion of phosphomannosyl-deficient arylsulphatase A and cathepsin D from isolated human macrophages.
    Muschol N; Matzner U; Tiede S; Gieselmann V; Ullrich K; Braulke T
    Biochem J; 2002 Dec; 368(Pt 3):845-53. PubMed ID: 12296771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.